Yahoo Web Search

Search results

    • Merck to Acquire EyeBio

      Morningstar· 16 hours ago

      Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...

    • Merck eyes purchase of ophthalmology company

      Merck eyes purchase of ophthalmology company

      WFMZ Eastern Pennsylvania and Western New Jersey· 5 hours ago

      Take Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...

    • Merck to buy eye drug developer for $1.3B

      Merck to buy eye drug developer for $1.3B

      BioPharma Dive via Yahoo Finance· 15 hours ago

      An acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.

    • Merck Announces Third-Quarter 2024 Dividend

      Morningstar· 1 day ago

      Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...

    • Vaccines Fast Facts - ABC17NEWS

      ABC17 NEWS· 8 hours ago

      The Centers for Disease Control and Prevention (CDC) provides vaccine recommendations by age, as well as by disease. For more than 100 years, there has been public discord ...